Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension

Authors: Charles D. Burger, Wenze Tang, Yuen Tsang, Sumeet Panjabi

Source: Pulmonary Circulation, Vol 14, Iss 3, Pp n/a-n/a (2024)

Subject Terms: claims, outcomes, real‐world, tolerability, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/ea14623c56694b43a0f9d5caea342257

Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study

Authors: Yuen Tsang, Michael Stokes, Yong‐Jin Kim, Rong Tilney, Sumeet Panjabi

Source: The Clinical Respiratory Journal, Vol 17, Iss 12, Pp 1209-1222 (2023)

Subject Terms: cost, disease progression, hospitalization, prostacyclin pathway agent, pulmonary arterial hypertension, selexipag, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/1752-6981; https://doaj.org/toc/1752-699X

Access URL: https://doaj.org/article/6e90ef9b6af64431a304ddf7d0d0b8ba

Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States

Authors: Harrison W. Farber, Hayley D. Germack, Nicole S. Croteau, Jason C. Simeone, Fei Tang, Carly J. Paoli, Gurinderpal Doad, Sumeet Panjabi, Teresa De Marco

Source: Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)

Subject Terms: pulmonary arterial hypertension, risk factors, treatment, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/eb2cf11ab5fb414097686cac9796847e

Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag

Authors: Yuen Tsang, Risho Singh, Sumit Verma, Sumeet Panjabi

Source: Rheumatology and Therapy, Vol 10, Iss 3, Pp 741-756 (2023)

Subject Terms: Pulmonary arterial hypertension, Selexipag, Connective tissue disease, Health care costs, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/2198-6576; https://doaj.org/toc/2198-6584

Access URL: https://doaj.org/article/b3ae782811fe4d53aefb60b787e2da4c

Impact of the COVID‐19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension‐specific therapy in the United States of America: An observational study

Authors: Marjorie Patricia George, Hayley D. Germack, Amit Goyal, Charlotte Ward, Sean Studer, Sumeet Panjabi

Source: Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)

Subject Terms: care access, COVID‐19, pulmonary hypertension, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/560083797319426c82be2411530670f8

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository

Authors: Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan

Source: Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)

Subject Terms: prescribing data, pulmonary arterial hypertension, real‐world evidence, registry, repository, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/9450ffb2f427410cb5f40faf8efb0c23

A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension

Authors: Bethany Hyde, Carly J. Paoli, Sumeet Panjabi, Katherine C. Bettencourt, Karimah S. Bell Lynum, Mona Selej

Source: Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)

Subject Terms: early diagnosis, rare disease, real‐world evidence, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/342a74dda5fd48bca1f83585d3436964

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)

Authors: Yuen Tsang, Sumeet Panjabi, Vienica Funtanilla, Hayley D. Germack, Marjolaine Gauthier‐Loiselle, Ameur M. Manceur, Stephanie Liu, Martin Cloutier, Patrick Lefebvre

Source: Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)

Subject Terms: healthcare costs, healthcare resource utilization, pulmonary hypertension, retrospective cohort study, systemic sclerosis, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779

File Description: electronic resource

Relation: https://doaj.org/toc/2045-8940

Access URL: https://doaj.org/article/1a7802320de94b8fb059854cd36ebf1a

Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US

Authors: Rafael Fonseca, May Hagiwara, Sumeet Panjabi, Emre Yucel, Jacqueline Buchanan, Thomas Delea

Source: Blood Cancer Journal, Vol 11, Iss 2, Pp 1-11 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2044-5385

Access URL: https://doaj.org/article/ddc0f98d0a31440b99138b5c61872540

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma

Authors: Joanna P MacEwan, Istvan Majer, Jacquelyn W Chou, Sumeet Panjabi

Source: Therapeutic Advances in Hematology, Vol 12 (2021)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2040-6215

Access URL: https://doaj.org/article/1a62d024e7a0434d8d6aa66de04d4deb

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis

Authors: Xue Song, Kathleen L. Wilson, Jerry Kagan, Sumeet Panjabi

Source: Therapeutic Advances in Hematology, Vol 10 (2019)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2040-6215

Access URL: https://doaj.org/article/6b6c52df7bf247279c3b66c63cef1e51

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting

Authors: Robert M. Rifkin, Rohan Medhekar, E. Susan Amirian, Kathleen M. Aguilar, Thomas Wilson, Marley Boyd, Khalid Mezzi, Sumeet Panjabi

Source: Therapeutic Advances in Hematology, Vol 10 (2019)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/2040-6215

Access URL: https://doaj.org/article/79f21fba59354e9a83f8f6d4f60056f2

Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension.

Authors: Lesley-Ann Miller, Rolin Wade, Dingwei Dai, Mark J. Cziraky, Krishnan Ramaswamy, Sumeet Panjabi

Source: Current Medical Research & Opinion; Jan2010, Vol. 26 Issue 6, p1307-1320, 14p

Subject Terms: ANGIOTENSIN II, THERAPEUTICS, HYPERTENSION, COST effectiveness, BLOOD pressure, DRUG design, VALSARTAN, LOSARTAN, IRBESARTAN